(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to the Oral Abstract Session: Genitourinary Cancer—Prostate, Testicular, and Penile.

OncoPilot is a promptable AI that claims to measure solid tumours in 3D with radiologist-level accuracy, in real time.

The Rare Inflammatory Disease Treatment Market has garnered a market value of USD 12,664 Million in 2021, anticipated to register a positive CAGR of 4.6% in the forecast period 2022 to 2028 and reach ...

The lab brings together patients, therapists, engineers and designers to come up with products and services to improve ...

Tracking the trajectory of symptoms may be an improvement over the traditional way of collecting patient-reported outcomes ...

AI agents are, at their core, software programs that interact with their environment, collect data, and autonomously perform tasks to meet predetermined goals. They represent an evolution from ...

LEO Pharma A/S, a global leader in medical dermatology, today announced the initiation of the phase 2a proof-of-concept DELTA NEXT trial. The trial aims to evaluate the efficacy and safety of ...

Actym Therapeutics has strengthened its IP portfolio with two newly issued patents covering its novel STACT™ biological ...

Global mRNA Cancer Vaccines Clinical Trials, Market Trends By Indication, Development Priority Status and Market Opportunity ...

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day follow-up results of TRINITY Trial of LuX-Valve Plus, a ...

In the CheckMate 274 study, adjuvant nivolumab demonstrated a significant improvement in disease-free survival (DFS) and showed a trend toward improved overall survival (OS) in an unselected ...